Investigational Site Number 124006

Montreal H3Z 1E5

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Diabetes Mellitus, Type 2, Prostate Cancer Metastatic

Studies at this site

• Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide — Stopped early
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed